Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical HCT and NK Cells with TLI Conditioning for Hematologic Malignancies
NCT01807611Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- May 2013
- Primary completion
- Aug 2021
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Natural Killer Cells in hematologic malignancy, leukemia, lymphoma, sponsored by St. Jude Children's Research Hospital. Started May 2013; status: completed.
02
Drugs
Natural Killer Cells
03
Conditions
hematologic malignancyleukemialymphoma
Beyond the preview
Go deeper on NCT01807611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01807611.